ArriVent BioPharma, Inc. Common Stock

$29.50
+0.46 (+1.58%)

Volume:

185.899K ($5.38M)

Market Capitalization:

$1.37B

ArriVent BioPharma Price Chart

ArriVent BioPharma Price Chart11:59 AM1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM29.5029.3429.1829.0228.8628.7028.54

ArriVent BioPharma Volume Chart

ArriVent BioPharma Volume Chart11:59 AM1:19 PM2:39 PM3:59 PM5:19 PM6:39 PM7:59 PM11.08K9.50K7.92K6.33K4.75K3.17K1.58K

ArriVent BioPharma Market Segments

After Hours

+0.00(+0.00%)
Open$29.50
Close$29.50
Low$29.50
Low Change0.00 (0.00%)
High$29.50
High Change+0.00 (+0.00%)
Range$0.00
Volume214
Dollar Volume$6.31K

Regular Trading Hours

-0.08(-0.26%)
Open$29.00
Close$28.93
Low$28.54
Low Change-0.46 (-1.59%)
High$29.32
High Change+0.32 (+1.10%)
Range$0.78
Volume177.124K
Dollar Volume$5.12M

Premarket

-0.20(-0.68%)
Open$29.20
Close$29.00
Low$28.91
Low Change-0.29 (-0.99%)
High$29.20
High Change+0.00 (+0.00%)
Range$0.29
Volume8.561K
Dollar Volume$248.27K

After Hours Yesterday

*No Trades in Segment

Regular Trading Hours Yesterday

+0.65(+2.29%)
Open$28.39
Close$29.04
Low$27.17
Low Change-1.22 (-4.30%)
High$29.40
High Change+1.01 (+3.56%)
Range$2.23
Volume319.023K
Dollar Volume$9.26M

Premarket Yesterday

*No Trades in Segment

ArriVent BioPharma Moving Averages

5 Day Moving Average (SMA5)$29.21
10 Day Moving Average (SMA10)$29.74
20 Day Moving Average (SMA20)$30.05
50 Day Moving Average (SMA50)$26.49
100 Day Moving Average (SMA100)$24.26
200 Day Moving Average (SMA200)$22.09

ArriVent BioPharma Statistics

Average Volume (30 Days)468.41K
P/E Ratio (Current)-8.08
EPS (Current)-$3.59
Dividend Yield0.00%
Free Cash Flow
Cash Ratio1.76
Current Ratio12.83
Quick Ratio12.83
Debt to Equity0.00
Enterprise Value$1.30B
EV to EBITDA-7.20
EV to Sales
Price to Book4.38
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.50%
Return on Equity-0.54%

ArriVent BioPharma Stock Splits

There have been no stock splits for ArriVent BioPharma (AVBP).

ArriVent BioPharma Dividends

There have been no dividends for ArriVent BioPharma (AVBP).